A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis. (2015)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201407-1264oc
PubMed Identifier: 25654354
Publication URI: http://europepmc.org/abstract/MED/25654354
Type: Journal Article/Review
Volume: 191
Parent Publication: American journal of respiratory and critical care medicine
Issue: 9
ISSN: 1073-449X